Mediso launches next generation MRI spectrometer spinScan®

BUDAPEST,Hungary,April 25,2023 --Mediso released their next generation MRI spectrometer spinScan® the successor to the previously used console in the nanoScan® MRI product line. The new spectrometer was optimized for MRI applications delivering an ultra-low-noise expandable RF front-end and real-time dynamic shimming.

Mediso launches next generation MRI spectrometer spinScan®

The spectrometer is interfaced with three Mediso developed software applications to deliver a complete MRI workflow: the Sequence Development Platform for absolute control over the pulse sequences and reconstruction algorithms,the FDA approved and clinically validated InterView™ FUSION and Nucline™ for routine acquisition planning,reconstruction,image post-processing and evaluation.

Gergő Bagaméry,Director of Preclinical Product Development at Mediso commented: "Our main goal was to have a dedicated MRI spectrometer that is optimized for image quality,and works seamlessly with our clinically validated software platforms. We believe it is a big jump in performance for our research scanners as well as perfect platform for a potential clinical / OEM product line."

The spinScan® spectrometer is based on a technology that has been continuously developed for 10+ years,featuring an FPGA SoC platform with highly scalable transceiver architecture enabling more than 128 receiver channels and microsecond gradient resolution with closed-loop control via high-speed optical interfaces. Eddy current compensation is realized through digital cross term pre-emphasis adjustment allowing for improved EPI image quality. The spinScan® spectrometer features Mediso's extensive pulse sequence library with a wide range of readily optimized imaging protocols including all relevant anatomical sequences as well as high-end neuroimaging and spectroscopy protocols.

The console creates a future proof platform for all nanoScan®MRI systems,especially empowering the standalone MRI's used for high-end preclinical research applications.

About Mediso:

Mediso,works in the field of medical imaging for 30+ years with a profile of development,manufacturing,selling and servicing standalone and multi-modality imaging devices. The company offers complete solutions from hardware design to evaluation and quantification software for clinical patient care and preclinical research.

Mediso has a leader position in the preclinical imaging market with over 300 commissioned systems around the world. Beyond the market leading nanoScan® PET/CT and SPECT/CT,Mediso also offers standalone MRI and integrated PET/MRI systems based on a cryogen-free magnet with 3T or 7T field strength and a PET insert for simultaneous PET/MRI imaging.

Products are sold directly or through a distribution network in 100+ countries worldwide.